Increased Risk of Recurrence of Non-Muscle Invasive Bladder Cancer Associated With Psychological Distress: A Prospective Cohort Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective The primary aim was to evaluate the influence of depressive and anxiety symptoms on the 1-year recurrence rate of non-muscle invasive bladder cancer (NMIBC) patients. The secondary aim was to examine the risk factors leading to psychological distress.Methods A total of 104 NMIBC patients were enrolled for interviews, and the Hospital Anxiety and Depression Scale (HADS) questionnaire survey was administered 1 month after their operation. Their cystoscopy results were followed up. The risk factors affecting their 1-year recurrence rate were evaluated through univariate analysis, Cox regression and Kaplan-Meier analysis. The risk factors causing depressive and anxiety symptoms were evaluated through univariate analysis and logistic regression.Results In addition to American Urological Association risk stratification, depressive symptoms were another independent risk factor for recurrence in NMIBC patients (HR: 2.493, 95% CI: 1.048–5.930, p=0.039), and the increase in the recurrence rate was highly significant in intermediate-risk patients (HR: 8.496, 95% CI: 2.178–33.138, p=0.019). Anxiety symptoms were not an independent risk factor for recurrence (HR: 1.655, 95% CI: 0.714–3.837, p=0.240). We also observed that the burden of medical expenses of NMIBC on the family was an independent risk factor for depressive symptoms (p=0.029) and anxiety symptoms (p=0.048); chronic pain was an independent risk factor for anxiety symptoms (OR: 3.447, 95% CI: 1.182–10.052, p=0.023).Conclusion Depression symptoms are an independent risk factor for recurrence in NMIBC patients. Moreover, the burden of medical expenses on the family is an independent risk factor for depressive and anxiety symptoms in NMIBC patients. Additionally, chronic pain is a risk factor for anxiety symptoms in NMIBC patients. This study provided a theoretical foundation for clinical oncologists to pay more attention to the mental health of NMIBC patients.
Abstract
Objective The primary aim was to evaluate the influence of depressive and anxiety symptoms on the 1-year recurrence rate of non-muscle invasive bladder cancer (NMIBC) patients. The secondary aim was to examine the risk factors leading to psychological distress.Methods A total of 104 NMIBC patients were enrolled for interviews, and the Hospital Anxiety and Depression Scale (HADS) questionnaire survey was administered 1 month after their operation. Their cystoscopy results were followed up. The risk factors affecting their 1-year recurrence rate were evaluated through univariate analysis, Cox regression and Kaplan-Meier analysis. The risk factors causing depressive and anxiety symptoms were evaluated through univariate analysis and logistic regression.Results In addition to American Urological Association risk stratification, depressive symptoms were another independent risk factor for recurrence in NMIBC patients (HR: 2.493, 95% CI: 1.048–5.930, p=0.039), and the increase in the recurrence rate was highly significant in intermediate-risk patients (HR: 8.496, 95% CI: 2.178–33.138, p=0.019). Anxiety symptoms were not an independent risk factor for recurrence (HR: 1.655, 95% CI: 0.714–3.837, p=0.240). We also observed that the burden of medical expenses of NMIBC on the family was an independent risk factor for depressive symptoms (p=0.029) and anxiety symptoms (p=0.048); chronic pain was an independent risk factor for anxiety symptoms (OR: 3.447, 95% CI: 1.182–10.052, p=0.023).Conclusion Depression symptoms are an independent risk factor for recurrence in NMIBC patients. Moreover, the burden of medical expenses on the family is an independent risk factor for depressive and anxiety symptoms in NMIBC patients. Additionally, chronic pain is a risk factor for anxiety symptoms in NMIBC patients. This study provided a theoretical foundation for clinical oncologists to pay more attention to the mental health of NMIBC patients.
참고문헌 (36)
- Saginala K, "Epidemiology of bladder cancer", Med Sci(Basel), 8, pp.15~ (2020)
- Rübben H, "Natural history and treatment of low and high risk superficial bladder tumors", J Urol, 139, pp.283~285 (1988)
- Flaig TW, "Bladder Cancer, Version 3. 2020, NCCN Clinical Practice Guidelines in Oncology", J Natl Compr Canc Netw, 18, pp.329~354 (2020)
- Schmidt S, "Quality of life in patients with non-muscle-invasive bladder cancer : one-year results of a multicenter", Urol Oncol, 33, pp.19~ (2015)
- Yoshimura K, "Impact of superficial bladder cancer and transurethral resection on general health-related quality of life : an SF-36 survey", Urology, 65, pp.290~294 (2005)
- Pham H, "Mental health implications in bladder cancer patients : a review", Urol Oncol, 37, pp.97~107 (2019)
- de Lima MM Jr, "Suicide in patients with genitourinary malignancies", Eur J Cancer Care (Engl), 26 (2017)
- Pinquart M, "Depression and cancer mortality : a metaanalysis", Psychol Med, 40, pp.1797~1810 (2010)
- Chan CM, "Effects of depression and anxiety on mortality in a mixed cancer group : a longitudinal approach using standardised diagnostic interviews", Psychooncology, 24, pp.718~725 (2015)
- Jazzar U, "Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States", Cancer, 124, pp.3127~3135 (2018)
- Batty GD, "Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies", BMJ, 356, pp.j108~ (2017)
- Zhou Q, "Chronic unpredictable mild stress accelerates the growth of bladder cancer in a Xenograft mouse model", Psychol Res Behav Manag, 13, pp.1289~1297 (2020)
- Sheng J, "The link between depression and chronic pain : neural mechanisms in the brain", Neural Plast, 2017, pp.9724371~ (2017)
- Zis P, "Depression and chronic pain in the elderly : links and management challenges", Clin Interv Aging, 12, pp.709~720 (2017)
- Zhuo M, "Neural mechanisms underlying anxiety-chronic pain interactions", Trends Neurosci, 39, pp.136~145 (2016)
- Gariépy G, "Social support and protection from depression : systematic review of current findings in Western countries", Br J Psychiatry, 209, pp.284~293 (2016)
- Zimmermann M, "Modifiable risk and protective factors for anxiety disorders among adults : a systematic review", Psychiatry Res, 285, pp.112705~ (2020)
- Lacerda MS, "Anxiety, stress and depression in family members of patients with heart failure", Rev Esc Enferm USP, 51, pp.e03211~ (2017)
- Zigmond AS, "The hospital anxiety and depression scale", Acta Psychiatr Scand, 67, pp.361~370 (1983)
- Li Q, "The Chinese version of hospital anxiety and depression scale : psychometric properties in Chinese cancer patients and their family caregivers", Eur J Oncol Nurs, 25, pp.16~23 (2016)
- Vodermaier A, "Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients : a systematic review and meta-analysis", Support Care Cancer, 19, pp.1899~1908 (2011)
- Bjelland I, "The validity of the Hospital Anxiety and Depression Scale. An updated literature review", J Psychosom Res, 52, pp.69~77 (2002)
- Zhang Z, "Illness perceptions are a potential predictor of psychological distress in patients with nonmuscle-invasive bladder cancer : a 12-month prospective, longitudinal, observational study", Psychol Health Med, 25, pp.969~979 (2020)
- Nunes SO, "Immune and hormonal activity in adults suffering from depression", Braz J Med Biol Res, 35, pp.581~587 (2002)
- Zorrilla EP, "The relationship of depression and stressors to immunological assays : a meta-analytic review", Brain Behav Immun, 15, pp.199~226 (2001)
- Leonard BE, "Stress and the immune system in the etiology of anxiety and depression", Pharmacol Biochem Behav, 54, pp.299~303 (1996)
- Anda RF, "Depression and the dynamics of smoking. A national perspective", JAMA, 264, pp.1541~1545 (1990)
- Sanhueza C, "Diet and the risk of unipolar depression in adults : systematic review of cohort studies", J Hum Nutr Diet, 26, pp.56~70 (2013)
- Milaneschi Y, "The association between low vitamin D and depressive disorders", Mol Psychiatry, 19, pp.444~451 (2014)
- Penninx BW, "Effects of social support and personal coping resources on depressive symptoms: different for various chronic diseases?", Health Psychol, 17, pp.551~558 (1998)
- DiMatteo MR, "Depression is a risk factor for noncompliance with medical treatment : meta-analysis of the effects of anxiety and depression on patient adherence", Arch Intern Med, 160, pp.2101~2107 (2000)
- Schneider AK, "The multifaceted immune regulation of bladder cancer", Nat Rev Urol, 16, pp.613~630 (2019)
- Sanli O, "Bladder cancer", Nat Rev Dis Primers, 3, pp.17022~ (2017)
- Hofmann SG, "The effect of mindfulnessbased therapy on anxiety and depression : a meta-analytic review", J Consult Clin Psychol, 78, pp.169~183 (2010)
- Lovejoy NC, "Cancer-related depression : Part I--neurologic alterations and cognitive-behavioral therapy", Oncol Nurs Forum, 27, pp.667~678 (2000)
- Ostuzzi G, "Antidepressants for the treatment of depression in people with cancer", Cochrane Database Syst Rev, 4, pp.CD011006~ (2018)